Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : 2009 Biotech Charity Contest -- Ignore unavailable to you. Want to Upgrade?

To: BulbaMan who wrote (169)	2/13/2009 5:16:21 PM
From: BulbaMan	Read Replies (1) \| Respond to of 418

2/13/09 update Whether the week was jinxed by a Friday the 13th occurrence or by the incantations of Treasury Secretary Geithner, we'll never know for sure. But investors seemed in a fearful mood. At Friday's close, the Nasdaq Composite Index was down -2.37% CYTD, or "Contest Year To Date" (vs. up 1.28% CYTD a week ago). The Nasdaq Biotech Index had a rough week as well, closing up 5.87% CYTD (vs. up 7.75% CYTD a week ago). And the Contest median did no better, closing up 4.26% CYTD (vs. up 8.02% CYTD a week ago). With a slight shift in order, the same three portfolios continued the battle for first place. At this week's close, the CYTD percentages were: GHMM up 21.91%, ENZYME up 21.04% and SCARAM up 18.55%. At Friday's close, 23 of the 32 Contest portfolios were in the black and 14 of the 32 beat the NBI. Enjoy the President's Day weekend folks! Below is the Top Ten list on 2/13/09: 2/13/09 Rank Name Profit/Loss 1 GHMM 21,909 2 ENZYME 21,041 3 SCARAM 18,548 4 PRAVN 13,221 5 ASHLEY 12,806 6 BULBA 12,540 7 CASA 11,867 8 ROBERT 10,300 9 RKRW 9,887 10 MOPGCW 9,579 (All corrections, especially adjustments for splits, greatly appreciated.)